Johnson & Johnson competitorsClear all

Johnson & Johnson's top competitors include Bayer, Pfizer, Procter & Gamble, Unilever, Colgate Palmolive, Reckitt Benckiser, Merck, Bristol-Myers Squibb, Roche, Novartis and Abbott.
Johnson & Johnson
Johnson & Johnson
Johnson & Johnson is a global holding company that engages in the research and development, manufacture and sale of a range of products in the healthcare field.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.
Procter & Gamble
Procter & Gamble
Procter & Gamble is a multinational consumer goods company offering personal care products, pet food, cleaning agents and more.
Unilever
Unilever
Unilever produces and supplies fast moving consumer goods in food, home, and personal care product categories.
Colgate Palmolive
Colgate Palmolive
Colgate-Palmolive is a consumer products company that produces and distributes household, healthcare, and personal care products.
Reckitt Benckiser
Reckitt Benckiser
Reckitt Benckiser is a consumer goods company producing health, hygiene, and home products.
Merck
Merck
Merck is a healthcare manufacturer and distributor of pharmaceuticals.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious and life-threatening diseases.
Roche
Roche
Roche (also known as F. Hoffmann-La Roch) is a biotech company operating through 2 segments: Pharmaceuticals and Diagnostics.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets a range of healthcare products.
Abbott
Abbott
Abbott is a healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines.
Founding Date
Founding Date
1886
Founding Date
1863
Founding Date
1849
Founding Date
1837
Founding Date
1929
Founding Date
1806
Founding Date
1823
Founding Date
1891
Founding Date
1887
Founding Date
1896
Founding Date
1996
Founding Date
1991
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
New Brunswick, US HQ
Buenos Aires, AR
Yerevan, AM
Ultimo, AU
Wien, AT
Minsk, BY
Beerse, BE
see more
Locations
Leverkusen, DE HQ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
Dhaka, BD
Minsk, BY
see more
Locations
New York, US HQ
Melrose Park, AU
Wien, AT
Minsk, BY
Ixelles, BE
Sofia, BG
Kirkland, CA
see more
Locations
Cincinnati, US HQ
Buenos Aires, AR
São Paulo, BR
Toronto, CA
Santiago, CL
Beijing, CN
Cairo, EG
see more
Locations
London, GB HQ
Munro, AR
Sydney, AU
Wien, AT
Dhaka, BD
Brussels, BE
Cochabamba, BO
see more
Locations
New York, US HQ
Llavallol, AR
Sydney, AU
Auderghem, BE
Praha 8, CZ
Bois Colombes, FR
Hamburg, DE
see more
Locations
Slough, GB HQ
Buenos Aires, AR
Sydney, AU
Wien, AT
Dhaka, BD
Anderlecht, BE
Sarajevo, BA
see more
Locations
Kenilworth, US HQ
Buenos Aires, AR
Adelaide, AU
Brisbane, AU
Canberra, AU
Perth, AU
Sydney, AU
see more
Locations
New York, US HQ
Braine L'alleud, BE
Montréal, CA
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Basel, CH HQ
Hydra, DZ
Ricardo Rojas, AR
Bella Vista, AU
North Ryde, AU
Sydney, AU
Wien, AT
see more
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Lake Bluff, US HQ
Tiranë, AL
Buenos Aires, AR
Yerevan, AM
Doncaster, AU
Macquarie Park, AU
Melbourne, AU
see more
Employees
Employees
132,2002% decrease
Employees
103,8241% decrease
Employees
88,3004% decrease
Employees
97,0005% increase
Employees
153,0005% decrease
Employees
34,3001% decrease
Employees
37,345
Employees
71,0003% increase
Employees
30,00029% increase
Employees
94,4421% increase
Employees
103,91417% decrease
Employees
107,0004% increase
Valuation ($)
Valuation ($)
391.9 b
Valuation ($)
68.4 b
Valuation ($)
212.1 b
Valuation ($)
287.3 b
Valuation ($)
139.6 b
Valuation ($)
61.7 b
Valuation ($)
62.4 b
Valuation ($)
199.5 b
Valuation ($)
135.3 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
162.9 b
Twitter followers
Twitter followers
196.7 k
Twitter followers
173.4 k
Twitter followers
18.2 k
Twitter followers
211.9 k
Twitter followers
220.6 k
Twitter followers
34.3 k
Twitter followers
19 k
Twitter followers
186.7 k
Twitter followers
141.8 k
Twitter followers
213.8 k
Twitter followers
268.7 k
Twitter followers
101.7 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
96
Number of tweets (last 30 days)
58
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
305
Number of tweets (last 30 days)
86
Number of tweets (last 30 days)
90
Number of tweets (last 30 days)
61
Number of tweets (last 30 days)
53
Number of tweets (last 30 days)
55
Number of tweets (last 30 days)
98
Number of tweets (last 30 days)
31
Number of tweets (last 30 days)
297
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
15.2
Average likes per tweet (last 30 days)
10.6
Average likes per tweet (last 30 days)
12.3
Average likes per tweet (last 30 days)
7
Average likes per tweet (last 30 days)
21
Average likes per tweet (last 30 days)
9.4
Average likes per tweet (last 30 days)
3.1
Average likes per tweet (last 30 days)
25.5
Average likes per tweet (last 30 days)
19.5
Average likes per tweet (last 30 days)
33.6
Average likes per tweet (last 30 days)
14.3
Average likes per tweet (last 30 days)
14.3
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
81.25%
Percentage of tweets with engagement (last 30 days)
65.52%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
62.62%
Percentage of tweets with engagement (last 30 days)
59.3%
Percentage of tweets with engagement (last 30 days)
74.44%
Percentage of tweets with engagement (last 30 days)
47.54%
Percentage of tweets with engagement (last 30 days)
98.11%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
98.98%
Percentage of tweets with engagement (last 30 days)
64.52%
Percentage of tweets with engagement (last 30 days)
51.85%
Alexa Website Rank
Alexa Website Rank
28232
Alexa Website Rank
94682
Alexa Website Rank
33553
Alexa Website Rank
19868
Alexa Website Rank
43104
Alexa Website Rank
256120
Alexa Website Rank
65817
Alexa Website Rank
100197
Alexa Website Rank
133722
Alexa Website Rank
91937
Alexa Website Rank
138421
Alexa Website Rank
35563
Employee Rating
Employee Rating
4.0
Employee Rating
N/A
Employee Rating
4.0
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
4.1
Employee Rating
3.4
Employee Rating
3.9
Employee Rating
3.9
Employee Rating
N/A
Employee Rating
3.9
Employee Rating
3.5

Financial

Revenue (est.)
Revenue (est.)
$82.1b (FY, 2019)
Revenue (est.)
€43.5b (FY, 2019)
Revenue (est.)
$51.8b (FY, 2019)
Revenue (est.)
$67.7b (FY, 2019)
Revenue (est.)
€52b (FY, 2019)
Revenue (est.)
$15.7b (FY, 2019)
Revenue (est.)
£12.6b (FY, 2018)
Revenue (est.)
$46.8b (FY, 2019)
Revenue (est.)
$26.1b (FY, 2019)
Revenue (est.)
CHF59.5b (FY, 2018)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
$31.9b (FY, 2019)
Cost of goods
Cost of goods
$27.6b (FY, 2019)
Cost of goods
€17.5b (FY, 2019)
Cost of goods
$10.2b (FY, 2019)
Cost of goods
$34.8b (FY, 2019)
Cost of goods
€29.1b (FY, 2019)
Cost of goods
$6.4b (FY, 2019)
Cost of goods
£5b (FY, 2018)
Cost of goods
$14.1b (FY, 2019)
Cost of goods
$8.1b (FY, 2019)
Cost of goods
CHF17.3b (FY, 2018)
Cost of goods
$17.2b (FY, 2017)
Cost of goods
$13.2b (FY, 2019)
Gross profit
Gross profit
$54.5b (FY, 2019)
Gross profit
€26.1b (FY, 2019)
Gross profit
$41.5b (FY, 2019)
Gross profit
$32.9b (FY, 2019)
Gross profit
€22.9b (FY, 2019)
Gross profit
$9.3b (FY, 2019)
Gross profit
£7.6b (FY, 2018)
Gross profit
$32.7b (FY, 2019)
Gross profit
$18.1b (FY, 2019)
Gross profit
CHF42.2b (FY, 2018)
Gross profit
$31.9b (FY, 2017)
Gross profit
$18.7b (FY, 2019)
Net income
Net income
$15.1b (FY, 2019)
Net income
€2.4b (FY, 2019)
Net income
$16.3b (FY, 2019)
Net income
$3.9b (FY, 2019)
Net income
€6b (FY, 2019)
Net income
$2.4b (FY, 2019)
Net income
£2.2b (FY, 2018)
Net income
$9.8b (FY, 2019)
Net income
$3.4b (FY, 2019)
Net income
CHF10.9b (FY, 2018)
Net income
$7.7b (FY, 2017)
Net income
$3.7b (FY, 2019)

Operating

Brands
Brands
N/A
Brands
N/A
Brands
N/A
Brands
65 (FY, 2017)
Brands
400 (FY, 2019)
Brands
N/A
Brands
20 (FY, 2017)
Brands
N/A
Brands
N/A
Brands
N/A
Brands
N/A
Brands
N/A
Countries
Countries
60 (FY, 2018)
Countries
153 (FY, 2018)
Countries
125 (FY, 2017)
Countries
180 (Q2, 2018)
Countries
190 (FY, 2019)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Manufacturing Facilities
Manufacturing Facilities
97 (FY, 2019)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
113 (FY, 2017)
Manufacturing Facilities
300 (FY, 2018)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Sites
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
58 (FY, 2017)
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
N/A
Manufacturing Sites
26 (FY, 2018)
Manufacturing Sites
N/A
Manufacturing Sites
92 (FY, 2019)
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
12 (Jan, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
19 (Apr, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
9 (Jan, 2020)
Phase III Trials Products
29 (FY, 2017)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
24 (Apr, 2020)
Phase III Trials Products
8 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
37 (FY, 2017)
Phase III Trials Products
N/A
Products
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
98 (Apr, 2020)
Products
N/A
Products
N/A
Products
N/A
Products
1.5 k (FY, 2018)
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
10 (May, 2018)
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Properties
Properties
N/A
Properties
N/A
Properties
501 (FY, 2017)
Properties
N/A
Properties
N/A
Properties
330 (FY, 2016)
Properties
N/A
Properties
N/A
Properties
N/A
Properties
N/A
Properties
N/A
Properties
N/A
Research and Development Centers
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
N/A
Research and Development Centers
30 (FY, 2018)
Research and Development Centers
N/A
Research and Development Centers
12 (FY, 2017)
Suppliers
Suppliers
3.5 k (Jun, 2018)
Suppliers
86.4 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A
Suppliers
175 (FY, 2018)
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
US FDA Breakthrough Therapy Designations
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
N/A
US FDA Breakthrough Therapy Designations
6 (FY, 2018)
US FDA Breakthrough Therapy Designations
6 (FY, 2017)
US FDA Breakthrough Therapy Designations
N/A

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 5m
Total funding raised
$ 15.5m
Total funding raised
$ 2.8b
Total funding raised
$ 6.5m
Total funding raised
$ 6.9m
For sources of this data, please see the company profile

View company profiles

Bayer
HQ
Leverkusen, DE
Employees
103,824↓ 1% decrease

Bayer is a global life science company specializing in healthcare and nutrition.

View company
Pfizer
HQ
New York, US
Employees
88,300↓ 4% decrease

Pfizer is a research-based biopharmaceutical company developing and manufacturing human and veterinary medicines, as well as consumer healthcare products.

View company
Procter & Gamble
HQ
Cincinnati, US
Employees
97,000↑ 5% increase

Procter & Gamble is a multinational consumer goods company offering personal care products, pet food, cleaning agents and more.

View company
Unilever
HQ
London, GB
Employees
153,000↓ 5% decrease

Unilever produces and supplies fast moving consumer goods in food, home, and personal care product categories.

View company